🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective is to evaluate the safety and tolerability of VRB-103...
Status
Recruiting
Location
Nucleus Network
Start Date
2026-07-06
Trial ID
NCT07628127
The purpose of this study is to identify the weekly oral dose of VRB-101 (o...
Status
Active Not Recruiting
Location
Clinical Study Site 202
Start Date
2026-06-12
Trial ID
NCT07553299
The aim of the study is to compare the efficacy and safety of XW003 injecti...
Status
Active Not Recruiting
Location
Peking University People's Hospital
Start Date
2025-07-28
Trial ID
NCT07073417
Treatments Being Tested
This is a study of a drug-drug interaction between XW003 and Metformin, War...
Status
Completed
Location
West China Second University Hospital, Sichuan University
Start Date
2023-07-14
Trial ID
NCT06335134
Treatments Being Tested
The aim of the study is to compare the efficacy and safety of two XW003 dos...
Status
Completed
Location
ZHONGSHAN Hospital
Start Date
2023-01-10
Trial ID
NCT05680129
Treatments Being Tested
The aim of the study is to assess the efficacy and safety of XW003 injectio...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2026-02-09
Trial ID
NCT07387094
Treatments Being Tested
The aim of this study is to evaluate the efficacy of VRB-101 for body weigh...
Status
Completed
Location
Clinical Study Site 103
Start Date
2025-11-25
Trial ID
NCT07281937
The main purpose of this study is to investigate the efficacy and safety of...
Status
Completed
Location
Nanjing Drum Tower Hospital
Start Date
2022-12-29
Trial ID
NCT05680155
Treatments Being Tested
XW004 is an acylated human glucagon-like peptide 1 (GLP-1) analogue and is ...
Status
Completed
Location
Q-Pharm Pty Ltd (AKA Nucleus Network Brisbane)
Start Date
2022-04-12
Trial ID
NCT05184322
The aim of the study is to evaluate the efficacy and safety of XW003 versus...
Status
Completed
Location
Peking University People's Hospital
Start Date
2023-04-05
Trial ID
NCT05813795
Treatments Being Tested